v3.26.3
Investments
3 Months Ended
Sep. 30, 2026
Investments, Debt and Equity Securities [Abstract]  
Investments Investments
The Company’s Investments reported in the accompanying consolidated balance sheets consisted of the following as of September 30, 2026 and June 30, 2026:
September 30,
2026
June 30,
2026
Equity method investments:
Hard Carry Gaming, Inc. (“HCG”)$5,084 $5,330 
MSG Networks— — 
Other equity method investments (a)
1,785 1,937 
Equity investments with readily determinable fair values:
Xtract One Technologies Inc. (“Xtract One”) common stock12,337 14,046 
Other equity investments with readily determinable fair values held in trust under the Company’s Executive Deferred Compensation Plan30,577 29,145 
Equity investments without readily determinable fair values (a)(b)
12,228 11,662 
Derivative instruments:
Xtract One warrants1,752 3,498 
Total investments$63,763 $65,618 
_________________
(a)During the three months ended September 30, 2026 and 2025, the Company did not record any impairments related to its other equity method investments or any impairment charges or changes in carrying value of its equity securities without readily determinable fair values in the accompanying consolidated statements of operations.
(b)During the three months ended September 30, 2026, the Company recognized income of $163 in Miscellaneous (expense) income, net within the accompanying consolidated statements of operations related to equity investments without readily determinable fair values. During the three months ended September 30, 2025, the Company recognized no income or loss related to equity investments without readily determinable fair values.
Equity Method Investments
HCG
The Company holds preferred shares of the capital stock of HCG, an online video production company. During the three months ended September 30, 2026 and 2025, the Company recognized its net share of income (losses) of $246 and $(274), respectively, in Miscellaneous (expense) income, net within the accompanying consolidated statements of operations. As of September 30, 2026 and June 30, 2026, the Company’s ownership in HCG was approximately 25%.
MSG Networks
In June 2025, the local telecast rights agreements between subsidiaries of MSG Networks, on the one hand, and New York Knicks, LLC (“Knicks LLC”) and New York Rangers, LLC (“Rangers LLC”), on the other hand, were amended as further described in Note 16. Concurrent with the amendments to the local telecast rights agreements, MSG Networks issued penny
warrants to the Company exercisable for 19.9% of the equity interests in MSG Networks. The Company has accounted for the penny warrants issued to the Company as in-substance common stock in accordance with ASC Topic 323, Investments — Equity Method and Joint Ventures, and the Company determined that it has the ability to exert significant influence over the investee. The Company recorded the investment in MSG Networks penny warrants at fair value as an equity method investment. The Company estimated the fair value of the MSG Networks warrants based on a discounted cash flow model (income approach). This approach relied on numerous assumptions and judgments within the model that were subject to various risks and uncertainties. Principal assumptions utilized, all of which are considered Level III inputs under the fair value hierarchy, include the Company’s estimates of future revenue, estimates of future operating cost, margin assumptions, terminal growth rates and the discount rate applied to estimated future cash flows.
During the three months ended September 30, 2026, the Company recognized its net share of income of MSG Networks of $547 in Miscellaneous (expense) income, net within the accompanying consolidated statements of operations. During the three months ended September 30, 2025, the Company recognized no income or loss related to the MSG Networks equity method investment.
During the three months ended September 30, 2026, the Company recorded an other than temporary impairment of $547 related to the MSG Networks equity method investment in Miscellaneous (expense) income, net within the accompanying consolidated statements of operations. During the three months ended September 30, 2025, the Company did not record any impairments related to the MSG Networks equity method investment.
In connection with the Rangers Distribution, the Company assigned a portion of the warrants exercisable for approximately 6.5% of the equity interests in MSG Networks.
Equity Investments with Readily Determinable Fair Values
The Company holds investments in equity instruments with readily determinable fair value:
•Xtract One, a technology-driven threat detection and security solution company that is listed on the Toronto Stock Exchange under the symbol “XTRA”. The Company holds common stock of Xtract One and holds warrants entitling the Company to acquire additional shares of common stock of Xtract One which are considered derivative instruments. Refer to Note 11 for further details regarding the Company’s warrants, including the inputs used in determining the fair value of the warrants.
•Other equity investments held in trust under the Company’s Executive Deferred Compensation Plan (the “Deferred Compensation Plan”). See Note 15 to the consolidated financial statements included in our 2026 Form 10-K for more information regarding the Deferred Compensation Plan. The Company recorded compensation expense of $140 and $963 for the three months ended September 30, 2026 and 2025, respectively, within Selling, general and administrative expenses within the accompanying consolidated statements of operations to reflect the remeasurement of the Deferred Compensation Plan liability. In addition, the Company recorded gains of $140 and $963 for the three months ended September 30, 2026 and 2025, respectively, within Miscellaneous (expense) income, net within the accompanying consolidated statements of operations to reflect the remeasurement of the fair value of assets under the Deferred Compensation Plan.
The fair value of the Company’s investments in common stock of Xtract One and other investments held in trust is determined based on quoted market prices in active markets, which are classified within Level I of the fair value hierarchy.
The cost basis and carrying value of equity investments with readily determinable fair values as of September 30, 2026 and June 30, 2026 were as follows:
September 30, 2026June 30, 2026
Cost BasisCarrying Value/Fair ValueCost BasisCarrying Value/Fair Value
Xtract One common stock$7,721 $12,337 $7,721 $14,046 
Other equity investments with readily determinable fair values23,474 30,577 22,182 29,145 
$31,195 $42,914 $29,903 $43,191 
The following table summarizes amounts recognized related to the Deferred Compensation Plan in the accompanying consolidated balance sheets as of September 30, 2026 and June 30, 2026:
September 30,
2026
June 30,
2026
Non-current assets (included in investments)$30,577 $29,145 
Current liabilities (included in accrued employee-related costs)(3,857)(3,821)
Non-current liabilities (included in other employee-related costs)(26,720)(25,324)
The following table summarizes the realized and unrealized gains (losses) on equity investments with readily determinable fair values, recorded within Miscellaneous (expense) income, net within the accompanying consolidated statements of operations, for the three months ended September 30, 2026 and 2025:
Three Months Ended September 30,
20262025
Unrealized (loss) gain - Xtract One common stock$(1,709)$8,826 
Unrealized gain - other equity investments with readily determinable fair values140 963 
$(1,569)$9,789